TotalMarketCap

Biofrontera

BFRINasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$12.030 M

$0.81 -10.38%

Close of 6 Nov 2026

As of 6 Nov 2026, Biofrontera (BFRI) has a market capitalization of $12.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$41.7M

#2771 by revenue

Earnings

-$10.5M

Loss-making

Shares outstanding

14,852,359

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Biofrontera lists more than one class of stock. Company figures above cover all classes combined.

BFRIW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #403Bolt BiotherapeuticsBOLT$12.6M
  2. #404Dare BioscienceDARE$12.3M
  3. #405BiofronteraBFRI$12.0M
  4. #406Tvardi TherapeuticsTVRD$11.5M
  5. #407AEON BiopharmaAEON$11.3M

What if Biofrontera were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,901,171

Per share 2,347,125× higher

Bitcoin $1.53T

$102,869.05

Per share 126,999× higher

Apple $5.02T

$337,709.49

Per share 416,925× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Biofrontera are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.